Cor Vasa 2012, 54(3-4):e113-e134 | DOI: 10.1016/j.crvasa.2012.03.002

Czech Society of Cardiology Guidelines for the Diagnosis and Treatment of Chronic Heart Failure 2011

Jindřich ©pinara, Jiří Vítovecb, Jaromír Hradecc, Ivan Málekd, Jaroslav Meluzínb, Lenka ©pinarováb, Lenka Hoąkovád, Markéta Hegarovád, Ondřej Ludkaa, Miloą Táborskýe
a Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
b I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny, Brno, Česká republika
c III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Vąeobecná fakultní nemocnice, Praha, Česká republika
d Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
e I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika

Keywords: Diagnóza; Léčba; Srdeční selhání

Received: March 7, 2012; Accepted: March 7, 2012; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©pinar J, Vítovec J, Hradec J, Málek I, Meluzín J, ©pinarová L, et al.. Czech Society of Cardiology Guidelines for the Diagnosis and Treatment of Chronic Heart Failure 2011. Cor Vasa. 2012;54(3-4):e113-134. doi: 10.1016/j.crvasa.2012.03.002.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail 2008;10:933-89. Go to original source... Go to PubMed...
    2. ©pinar J, Hradec J, Meluzín J, et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor Vasa 2007;49:K5-34.
    3. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46. Go to original source... Go to PubMed...
    4. Stewart S, MacIntyre K, Hole DJ, et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22. Go to original source... Go to PubMed...
    5. Rosolová H, Čech J, ©imon J, et al. Short to long term mortality of patients hospitalized in the Czech Republic - report from the EuroHeart Failure Survey. Eur J Heart Fail 2005;7:780-3. Go to original source... Go to PubMed...
    6. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report from the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005;112:1825-52. Go to original source...
    7. Leier CV. Examining the jugular vein is never in vain. Circ Heart Fail 2010;3:175-7. Go to original source... Go to PubMed...
    8. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63. Go to original source... Go to PubMed...
    9. Rame JE, Dries DL, Drazner MH. The prognostic value of the physical examination in patients with chronic heart failure. Congest Heart Fail 2003;9:170-8. Go to original source...
    10. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007;9:1064-9. Go to original source... Go to PubMed...
    11. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. Go to original source... Go to PubMed...
    12. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733-9. Go to original source... Go to PubMed...
    13. ©pinar J, Vítovec J, Bláha M, et al. Radiologic changes in chronic heart failure. Cor Vasa 1992;34:88-99.
    14. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33. Go to original source... Go to PubMed...
    15. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50. Go to original source... Go to PubMed...
    16. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures. Circulation 2000;102:1788-94. Go to original source...
    17. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93. Go to original source... Go to PubMed...
    18. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 2006;25:1024-42. Go to original source... Go to PubMed...
    19. Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-24. Go to original source... Go to PubMed...
    20. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006;48:2610. Go to original source... Go to PubMed...
    21. Pilote L, Abrahamowitz M, Rodrigues E, et al. Mortality rates in elderly patients who take different angiotensin enzyme converting inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 2004;141:102-12. Go to original source...
    22. Hansen ML, Gislason GH, Køber L, et al. Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction. Br J Clin Pharmacol 2008;65:217-23. Go to original source... Go to PubMed...
    23. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 1999;100:2312-8. Go to original source...
    24. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35. Go to original source... Go to PubMed...
    25. The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.
    26. Yusuf S, Sleight P, Pogue, J et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53. Go to original source...
    27. McMurray J, Cohen-Solal A, Dietz R, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 2005;7:710-21. Go to original source... Go to PubMed...
    28. Cleland J, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27:2338-45. Go to original source... Go to PubMed...
    29. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-67. Go to original source... Go to PubMed...
    30. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81. Go to original source... Go to PubMed...
    31. Konstam M, Neaton JD, Drexler H, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009;374:1840-8. Go to original source... Go to PubMed...
    32. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-90. Go to original source...
    33. Remme WJ. Should ACE inhibition always be first-line therapy in heart fauilure? Lessons from the CARMEN Study. Cardiovasc Drugs Ther 2003;17:107-9. Go to original source... Go to PubMed...
    34. Willenheimer R, van Veldhuisen DJ, Silke B, et al; on behalf of the CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005;112:2426-35. Go to original source... Go to PubMed...
    35. Anand IS, Florea VG. Diuretics in chronic heart failure - benefits and hazards. Eur Heart J 2001;3(Suppl G):G8-18. Go to original source...
    36. Haller C. Diuretics in congestive heart failure: new evidence for old problems. Nephrol Dial Transplant 1999;14:1358-60. Go to original source...
    37. Reyes AJ, Taylor SH. Diuretics in cardiovascular therapy: the new clinicopharmacological bases that matter. Cardiovasc Drug Ther 1999;13:371-98. Go to original source...
    38. Konstam MA, Gheorghiade M, Burnett JC Jr., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007;297:1319-31. Go to original source... Go to PubMed...
    39. Zannad F, McMurray JJ, V Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21. Go to original source... Go to PubMed...
    40. Berry C, McMurray JJ. Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart 2001;85:E8. Go to original source... Go to PubMed...
    41. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33. Go to original source... Go to PubMed...
    42. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-11. Go to original source... Go to PubMed...
    43. Hood WB Jr., Dans AL, Guyatt GH, et al. Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. J Card Fail 2004;10:155-64. Go to original source... Go to PubMed...
    44. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8. Go to original source...
    45. Beemath A, Stein PD, Skaf E, et al. Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 2006;98:793-5. Go to original source... Go to PubMed...
    46. Witt BJ, Gami AS, Ballman KV, et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail 2007;13:489-96. Go to original source... Go to PubMed...
    47. de Peuter OR, Kok WE, Torp-Pedersen C, et al. Systolic heart failure: a prothrombotic state. Semin Thromb Hemost 2009;35:497-504. Go to original source... Go to PubMed...
    48. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm. Circulation 2001;103:1746-51. Go to original source...
    49. Bettari L, Fiuzat M, Becker R, et al. Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm current status and future directions. Circ Heart Fail 2011;4:361-8. Go to original source... Go to PubMed...
    50. Cokkinos DV, Harabalopoulos GC, Kostis JB, Toutouzas PK; HELAS investigators. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS Study. Eur J Heart Fail 2006;8:428-32. Go to original source... Go to PubMed...
    51. Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:807-16. Go to original source... Go to PubMed...
    52. Swedberg K, Komajda M, Böhm M, et al; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:886-94. Go to original source... Go to PubMed...
    53. Dormans TP, Huige RM, Gerlag PG. Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. Heart 1996;75:349-51. Go to original source... Go to PubMed...
    54. Jaski BE, Ha J, Denys BG, et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003;9:227-31. Go to original source... Go to PubMed...
    55. Dickstein K, Bogale N, Priori S, et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60. Go to original source... Go to PubMed...
    56. Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure. Eur Heart J 2010;31:2677-87. Go to original source... Go to PubMed...
    57. Al Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: Cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-12. Go to original source... Go to PubMed...
    58. Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy - the magnitude of the problem and the issues. Circ J 2011;75:521-7. Go to original source... Go to PubMed...
    59. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33. Go to original source...
    60. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al; the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrilator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50. Go to original source... Go to PubMed...
    61. Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2311-21. Go to original source... Go to PubMed...
    62. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and heart failure. N Engl J Med 2005;352:1539-49. Go to original source... Go to PubMed...
    63. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-8. Go to original source... Go to PubMed...
    64. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16. Go to original source... Go to PubMed...
    65. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al; MIRACLE Study Group; Multicenter Insync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl Med 2002;346:1845-53. Go to original source... Go to PubMed...
    66. Moss AJ, Hall WJ, Cannon DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events (MADIT-CRT). N Engl J Med 2009;361:1329-38. Go to original source... Go to PubMed...
    67. Linde C, Gold M, Abraham WT, et al. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure - the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006;151:288-94. Go to original source... Go to PubMed...
    68. Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy: insights from the European cohort of the REVERSE trial. Am Coll Cardiol 2009;54:1837-46. Go to original source... Go to PubMed...
    69. Gasparini M, Auricchio A, Metra M, et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008;29:1644-52. Go to original source... Go to PubMed...
    70. Gasparini M, Steinberg JS, Arshad A, et al. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J 2010;31:976-83. Go to original source... Go to PubMed...
    71. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-37. Go to original source... Go to PubMed...
    72. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123-34. Go to original source... Go to PubMed...
    73. Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report - 2005. J Heart Lung Transplant 2005;24:1182-7. Go to original source... Go to PubMed...
    74. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: More than 1000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10. Go to original source... Go to PubMed...
    75. Zimpfer D, Zrunek P, Sandner S, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular devices. Eur J Cardiothorac Surg 2007;31:698-702. Go to original source... Go to PubMed...
    76. Velazquez EJ, Kerry LL, Deja MA. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-16. Go to original source... Go to PubMed...
    77. Goodlin SJ, Hauptman PJ, Arnold R, et al. Consensus Statement: Palliative and Supportive Care in Advanced Heart Failure. J Cardiac Fail 2004;10:200-9. Go to original source... Go to PubMed...
    78. Hershberger RE, Nauman D, Walker TL, et al. Care Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003;9:180-7. Go to original source... Go to PubMed...
    79. Stevenson LW. The cul-de-sac at the end of the road. J Card Fail 2003;9:180-7. Go to original source... Go to PubMed...
    80. Jaarsma T, Beattie JM, Ryder M. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the ESC. Eur J Heart Fail 2009;11:433-43. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes